WallStreetZenWallStreetZen

NASDAQ: ACRV
Acrivon Therapeutics Inc Stock Ownership - Who owns Acrivon Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Acrivon Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mary MillerChief Legal Officer2024-04-17558$10.34
$5.77kSell
Perceptive Advisors LLC10% Owner2024-04-112,353,000$8.50
$20.00MBuy
Ra Capital Management LPDirector2024-04-113,530,000$8.50
$30.01MBuy
Erick GamelinChief Development Officer2024-02-14468$3.40
$1.59kSell
Peter BlumejensenPresident and CEO2024-02-1441,861$3.40
$142.33kSell
Eric DevroeChief Operating Officer2024-02-14723$3.40
$2.46kSell
Rasmus HolmjorgensenChief Financial Officer2024-02-14434$3.40
$1.48kSell
Kristina MassonEVP - Business Operations2024-02-14579$3.40
$1.97kSell
Mary MillerChief Legal Officer2024-02-14217$3.40
$737.80Sell
Mary MillerChief Legal Officer2024-01-17652$4.35
$2.84kSell

1 of 3

ACRV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRV insiders and whales buy or sell their stock.

ACRV Shareholders

What type of owners hold Acrivon Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC23.68%5,360,858$56.50MInsider
Ra Capital Management LP21.25%4,810,508$50.70MInstitution
Chione Ltd17.00%3,848,632$40.56MInsider
Kristina Masson16.82%3,806,895$40.12MInsider
Peter Blumejensen14.26%3,229,036$34.03MInsider
Perceptive Advisors LLC13.29%3,007,858$31.70MInstitution
Sands Capital Ventures LLC7.30%1,652,605$17.42MInstitution
Citadel Advisors LLC7.29%1,649,659$17.39MInstitution
Wellington Biomedical Innovation Master Investors Cayman I LP3.92%888,130$9.36MInsider
Wellington Management Group LLP3.92%888,130$9.36MInstitution

1 of 3

ACRV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRV46.35%53.65%Net BuyingNet Buying
XFOR57.63%1.30%Net SellingNet Selling
MACK23.49%76.51%Net Buying
GTHX24.18%47.08%Net SellingNet Selling
DSGN42.98%57.02%Net BuyingNet Buying
View Top Biotech Stocks

Acrivon Therapeutics Stock Ownership FAQ

Who owns Acrivon Therapeutics?

Acrivon Therapeutics (NASDAQ: ACRV) is owned by 67.57% institutional shareholders, 78.21% Acrivon Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Acrivon Therapeutics shareholder, owning 5.36M shares representing 23.68% of the company. Perceptive Advisors LLC's Acrivon Therapeutics shares are currently valued at $50.34M.

If you're new to stock investing, here's how to buy Acrivon Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.